AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score.

Authors

Nasir Shariff, Lehigh Valley Health NetworkFollow
Abdul Aleem, Sri Siddhartha Medical College
Mukesh Singh, Finch University of Health Sciences/The Chicago Medical School
Yuan Z Li, Lehigh Valley Health Network
Stacey Smith MD, FACP, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

10-1-2012

Abstract

Atrial fibrillation (AF) and venous thromboembolism (VTE) are the two most common medical conditions managed with anti-coagulation therapy. Not all the patients with decreased mobility or AF have a similar risk for thromboembolism. The risk factors for venous thromboembolism and thromboembolism associated with AF are described in various studies. Considering that the two conditions have similar pathophysiologic basis of clot formation, one could imply that the risk factors for the occurrence of thrombosis could be similar. The present review focuses on the similarities and differences in the clinical risk factors of VTE and AF related thromboembolism. We will also be discussing the role of CHADS

Volume

5

Issue

3

First Page

649

Last Page

649

ISSN

1941-6911

Published In/Presented At

Shariff, N., Aleem, A., Singh, M., Z Li, Y., & J Smith, S. (2012). AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score. Journal of atrial fibrillation, 5(3), 649. https://doi.org/10.4022/jafib.649

Disciplines

Cardiology | Internal Medicine

PubMedID

28496776

Department(s)

Department of Medicine, Cardiology Division

Document Type

Article